Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells

Background: Prostate cancer is the second leading cause of cancer-related deaths in Western countries. Most patients diagnosed with advanced prostate cancer can be treated with the main treatment: androgen deprivation therapy (ADT). The androgen receptor (AR) signaling axis plays a pivotal role in t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Onco Targets Ther
Autores principales: Cui, Luwei, Liu, Ming, Lai, Shicong, Hou, Huimin, Diao, Tongxiang, Zhang, Dalei, Wang, Miao, Zhang, Yaoguang, Wang, Jianye
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556480/
https://ncbi.nlm.nih.gov/pubmed/31239713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S193480
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares